Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Journal of Translational Medicine

Figure 4

From: In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor

Figure 4

Photographs of simultaneous staining of 30 week old breast tumors arising in HER-2/neu transgenic mice illustrating that over expression of HER-2/neu correlates down regulation of h tid. ErbB-2 was detected using a polyclonal chicken anti rat ErbB-2 and a FITC labelled secondary antibody. Tid was detected using the rabbit polyclonal anti hTid antibody [6, 7, 13] and a Texas Red labelled secondary antibody. The tumor cells over expressing ErbB-2 (A, arrowhead) are characterized by low tid expression (B, arrowhead; cf. Figure 3). In C an overlay of the photographs shown in A and B is presented.

Back to article page